Results 311 to 320 of about 3,310,854 (363)

Dermatologic adverse events to chemotherapeutic agents, Part 2: BRAF inhibitors, MEK inhibitors, and ipilimumab.

Seminars in cutaneous medicine and surgery, 2014
The advent of novel targeted chemotherapeutic agents and immunotherapies has dramatically changed the arena of cancer treatment in recent years. BRAF inhibitors, MEK inhibitors, and ipilimumab are among the newer chemotherapy drugs that are being used at
Jennifer N. Choi
semanticscholar   +1 more source

IMMUNOSUPPRESSIVE AGENTS IN DERMATOLOGY

Dermatologic Clinics, 1998
Azathioprine, cyclophosphamide, methotrexate, and cyclosporine are the immunosuppressive agents most commonly used by dermatologists. Azathioprine has a relatively good safety profile and is therefore often preferred for the treatment of chronic eczematous dermatitides and bullous disorders.
Vincent C. Ho, Jan P. Dutz
openaire   +3 more sources

Dermatologic adverse events to chemotherapeutic agents, part 1: cytotoxics, epidermal growth factor receptors, multikinase inhibitors, and proteasome inhibitors.

Seminars in cutaneous medicine and surgery, 2014
Dermatologic toxicities have profound effects on patients receiving chemotherapy for cancer treatment. Cytotoxic chemotherapies are associated with a number of nonspecific dermatologic adverse events including alopecia, mucositis, and onychodystrophy ...
R. Kyllo, M. Anadkat
semanticscholar   +1 more source

Cold atmospheric pressure plasmas in dermatology: Sources, reactive agents, and therapeutic effects

, 2020
Recently, cold atmospheric pressure plasmas (CAPs) have provided many new opportunities in dermatology by providing a multimodal action of reactive agents (RA).
Dawei Liu, Yanzhe Zhang, Maoyuan Xu, Hongxiang Chen, Xinpei Lu, K. Ostrikov   +5 more
semanticscholar   +1 more source

Topical hemostatic agents for dermatologic surgery.

The Journal of Dermatologic Surgery and Oncology, 1988
Topical hemostatic agents are very helpful in attaining capillary and small vessel hemostasis in dermatologic surgery. The commonly used topical hemostatic agents, including oxidized cellulose, absorbable gelatin, and thrombin are reviewed, along with ...
P. Larson
semanticscholar   +2 more sources

Topical Antibacterial Agents in Dermatology

The Journal of Dermatology, 2003
AbstractTopical antibacterials are being widely used for the treatment or prevention of superficial bacterial infections. Emergence of drug resistant mutant strains of microorganisms and development of irritant and allergic contact dermatitis is a common problem with many of the topical antibacterials.
Anjum Singal, Gurvinder P. Thami
openaire   +3 more sources

A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1.

Dermatitis, 2009
Biologic therapies are an efficacious new method of controlling a number of chronic conditions. Data regarding these medications continues to emerge, giving clinicians a greater understanding of their side effects profiles.
M. Bremmer, A. Deng, A. Gaspari
semanticscholar   +1 more source

Psychotropic Agents in Dermatology

Dermatologic Clinics, 1993
In this article, relatively detailed explanation of the use of selected psychopharmacologic agents is given along with their dermatologic and psychodermatologic indications. For a more complete description of the use of these medications, the reader is advised to consult standard textbooks on psychopharmacology and the Physician's Desk Reference.
openaire   +3 more sources

Dermatologic Therapy With Immunosuppressive Agents

Postgraduate Medicine, 1975
The use of powerful immunosuppressive agents such as methotrexate, cyclophosphamide, and azathioprine in the treatment of serious skin diseases is a relatively recent development whose efficacy is borne out in many studies. Using an immunosuppressant often makes possible an appreciable reduction in dosage of steroid necessary to control disease and, in
Robert I. Rudolph, James J. Leyden
openaire   +3 more sources

Cytokine blocking agents in dermatology

Clinical and Experimental Dermatology, 2002
Cytokines are intercellular messengers that have an important role in the development and maintenance of cutaneous inflammation. The primacy of cytokines in eliciting cutaneous immune responses makes them a highly attractive target for new biological response modifiers. Targeting of cytokines is still in its infancy for therapy of skin disease. However,
Williams, Jason D L, Griffiths, C. E M
openaire   +3 more sources